Education
About Us
Working with TipRanks
Follow Us
Ilya M Rachman Insider Profile
4 Followers
Ilya M Rachman, CEO & Chairman, Director at Immix Biopharma, holds 1.14M shares in Immix Biopharma (Ticker: IMMX). Most recently, Ilya M Rachman Bought 746 shares of Immix Biopharma on Dec 10, 2025 for an estimated value of $4.98K.
Ilya M Rachman Immix Biopharma (IMMX)CEO & Chairman, Director
Immix Biopharma (IMMX)
CEO & Chairman, Director
Ranked #454 out of 106,487 Corporate Insiders
Profitable Transactions
6 out of 8 Profitable Transactions
Average Return
+136.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO & Chairman, Director
Roles that Ilya M Rachman holds in companies
Most Profitable Insider Trade
The most profitable trade made by Ilya M Rachman
Ilya M Rachman's Trading History
List of latest transactions for each holding click on a transaction to see Ilya M Rachman's performance on stock
You May Also Like
Ilya M Rachman insider profile FAQ
What is the percentage of profitable transactions made by Ilya M Rachman?
The percentage of profitable transactions made by Ilya M Rachman is 75%.
What is the average return per transaction made by Ilya M Rachman?
The average return per transaction made by Ilya M Rachman is 136.80%.
What stocks does Ilya M Rachman hold?
Ilya M Rachman holds: IMMX stocks.
What was Ilya M Rachman’s latest transaction?
Ilya M Rachman latest transaction was an Informative Buy of $4.98K.
What was Ilya M Rachman's most profitable transaction?
Ilya M Rachman’s most profitable transaction was an Informative Buy of IMMX stock on September 17, 2025. The return on the trade was 410.20%.
What is Ilya M Rachman's role in Immix Biopharma?
Ilya M Rachman's role in Immix Biopharma is CEO & Chairman, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.